Cookies used for improved website experience

Siemens Healthineers and our partners use cookies and other similar technologies to operate the Siemens Healthineers websites and personalize content and ads. You may find out more about how we use cookies by clicking "Show details" or by referring to our Cookie Policy.
You may allow all cookies or select them individually. And you may change your consent and cookie preferences anytime by clicking on the "Review and change your consent" button on the Cookie Policy page.

Arthur J.E. Child Comprehensive Cancer Centre in Calgary, Alberta, Canada. Source: Alberta Health Services
Press release

Government of Alberta Invests $800 million CAD to Improve Cancer Care, Partnering with Siemens Healthineers and Alberta Cancer Foundation

Published on March 21, 2025
  • Addressing rise in cancer cases, reducing wait times for patients and supporting early detection 
  • Establishing two centers of excellence for training and AI 
  • $175 million CAD additional investment by Siemens Healthineers 

Alberta’s government is partnering with Siemens Healthineers and the Alberta Cancer Foundation to improve health outcomes for cancer patients in the Canadian province of Alberta. Within the framework of a Value Partnership1, the government of Alberta will invest $800 million CAD (around $560 million USD) over eight years to support early detection, reduce wait times and establish Alberta as a leader in cancer research and innovation. In addition, Siemens Healthineers will invest $175 million CAD to support establishing two centers of excellence as well as research. 

Danielle Smith, premier of Alberta said: “This investment will position our province as a leader in cancer care by leveraging artificial intelligence, attracting health care professionals, and supporting researchers in developing innovative cancer care solutions. From prevention to detection to treatment, we are ensuring Albertans facing cancer receive the best care available.” 

Alberta’s population is growing and aging, cancer cases are rising, and patients are facing longer wait times. To address these issues, Siemens Healthineers will replace existing oncology treatment and imaging equipment while introducing innovative technologies along with consulting and additional solutions to improve overall healthcare delivery. This work will begin, and start benefiting Albertans, almost immediately. 

Arthur Kaindl, head of Varian at Siemens Healthineers, said: “Together, we will advance care for Albertan cancer patients through AI, education, research, and innovation. By addressing the entire cancer care continuum, we are working toward a world without fear of cancer.” 

Adriana LaGrange, Alberta’s minister of health said: “This partnership will reduce wait times and patient expenses while increasing capacity across the health care system. It will also provide a significant return on investment into targeted oncology areas like education, research, artificial intelligence and machine learning to better support patients and our workforce.” 

The Value Partnership will create two centers of excellence in cancer care: one focused on oncology training and one focused on artificial intelligence and machine learning. In addition, a medical-research and innovation fund managed by the Alberta Cancer Foundation will be established to attract and retain global talent. In total, Siemens Healthineers will invest $175 million CAD in these three projects. 

“We’re proud to be part of this transformative initiative, advancing outcomes and expanding access to care for cancer patients in Alberta while making a positive, lasting impact on communities across the province,” said Sevket On, head of Canada at Siemens Healthineers. 

Wendy Beauchesne, chief executive officer of Alberta Cancer Foundation, said: “This is a major leap forward for cancer care in Alberta and will fuel vital cancer research. We're proud to be a partner in moving the needle here at home and a catalyst for bringing more effective, personalized treatments to patients sooner.”

Further information on Value Partnerships can be found here.

1

Siemens Healthineers 2025

Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2024, which ended on September 30, 2024, Siemens Healthineers had approximately 72,000 employees worldwide and generated revenue of around €22.4 billion. Further information is available at www.siemens-healthineers.com.